100 项与 CAR-T cell therapy(Tianjin Timmune Biotech Inc) 相关的临床结果
100 项与 CAR-T cell therapy(Tianjin Timmune Biotech Inc) 相关的转化医学
100 项与 CAR-T cell therapy(Tianjin Timmune Biotech Inc) 相关的专利(医药)
3
项与 CAR-T cell therapy(Tianjin Timmune Biotech Inc) 相关的文献(医药)2024-02-05·Cell reports. Medicine
An anti-CD19/CTLA-4 switch improves efficacy and selectivity of CAR T cells targeting CD80/86-upregulated DLBCL.
Article
作者: Lars Fabian Prinz ; Tobias Riet ; Daniel Felix Neureuther ; Simon Lennartz ; Danuta Chrobok ; Hanna Hübbe ; Gregor Uhl ; Nicole Riet ; Petra Hofmann ; Marianna Hösel ; Adrian Georg Simon ; Luis Tetenborg ; Paul Segbers ; Joji Shimono ; Philipp Gödel ; Hyatt Balke-Want ; Ruth Flümann ; Gero Knittel ; Hans Christian Reinhardt ; Christoph Scheid ; Reinhard Büttner ; Björn Chapuy ; Roland Tillmann Ullrich ; Michael Hallek ; Markus Martin Chmielewski
2017-01-01·Cell Research1区 · 生物学
Immune targets and neoantigens for cancer immunotherapy and precision medicine
1区 · 生物学
Review
作者: Wang, Rong-Fu ; Wang, Helen Y.
2014-01-01·Stem cell investigation
Chimeric antigen receptor (CAR)-directed adoptive immunotherapy: a new era in targeted cancer therapy.
Article
作者: Yamei Chen ; Delong Liu
100 项与 CAR-T cell therapy(Tianjin Timmune Biotech Inc) 相关的药物交易